Tag Archives: Organicell Regenerative Medicine

First use of an amniotic fluid-derived extracellular vesicles biologic as a therapeutic treatment for respiratory failure induced by COVID-19 infection

exosomes

Organicell Regenerative Medicine, a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced the publication of a peer-reviewed case report analyzing the clinical outcomes of Zofin treatment in three critically ill patients suffering from severe, multi-organ complications ...

Read More »